Medicover revenue and financials
kr 260.00Change from previous close: +0.19%Absolute change: +kr 0.50
In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.69%
- 2025 vs 2024
- Net income growth
- +364.07%
- 2025 vs 2024
- Net margin
- 3.3%
- 2024: 0.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 2,378 | 2,092 | 1,746 | 1,510 | — |
| Cost of revenue | 1,827 | 1,644 | 1,387 | 1,175 | — |
| Gross profit | 551 | 448 | 359 | 335 | — |
| Selling, general and administrative | 112 | 93.7 | 61.0 | 64.2 | — |
| Operating income | 156 | 86.7 | 61.2 | 56.7 | — |
| EBIT | 162 | 78.9 | 75.0 | 54.0 | — |
| EBITDA | 377 | 277 | 258 | 216 | — |
| Interest expense | 64.0 | 58.8 | 51.4 | 34.5 | — |
| Pre-tax income | 98.4 | 20.1 | 23.6 | 19.5 | — |
| Income tax | 25.7 | 5.5 | 5.2 | 5.8 | — |
| Net income | 77.5 | 16.7 | 17.6 | 11.8 | — |
| Net income to common shareholders | 77.5 | 16.7 | 17.6 | 11.8 | — |
| Basic EPS | 0.51 | 0.11 | 0.12 | 0.08 | — |
| Diluted EPS | 0.51 | 0.11 | 0.12 | 0.08 | — |
| Average shares (basic) | 151 | 150 | 149 | 149 | — |
| Average shares (diluted) | 151 | 150 | 150 | 149 | — |